In the present study, we analyzed the association of tumor p16 expression with prognosis in a retrospectively collected cohort of patients with HNSCC treated with RT+EGFR inhibitors or RT+CT. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.